Codeine Market - Uses, Interactions, Mechanism of Action, Dosage, Side Effects, and Addiction: challenges and opportunities Analysis, 2021 – 2026

Global Codeine Market Analysis

Overview

Codeine is an opioid medication that is commonly used to treat and manage mild to moderate pain, severe discomfort, dry annoying cough, diarrhea, and cold and flu symptoms (when combined with antihistamines and decongestants). Pain alleviation, sleep, joy, and happiness are all effects of opioids when they interact with opioid receptors in the brain. Codeine occurs in a variety of forms, including pills, capsules, and solutions/syrups, and is commonly ingested.

Get Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/2297

Drivers

In the therapy and management of symptoms and cough, codeine is commonly utilized. High incidence of pain owing to an ageing population in major regions like North America and Asia-Pacific is likely to fuel global codeine market growth over the forecast period.

As per the National Health Interview Survey (NHIS) statistics from 2016, it was projected that 20.4 percent (50.0 million) of individuals in the U.S. suffer from chronic pain, with 8.0 percent (19.6 million) having from high-impact chronic pain.

As per a research released by the National Center for Biotechnology Information (NCBI) in 2015, roughly 19.6% of people aged 20 to 60 years old globally struggle with low back pain.

Tailored Information as per niche requirement:

LIMITED TIME OFFER - Hurry Up!

Exclusive offer!!! Purchase the report at a discounted rate!!!

Get Discount For Buyers UPTO 30% OFF On Any Research Report

Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/2297

Regional Insights

Due to the high presence of important companies in the area and their approval and introduction of innovative products in the territory, the North American codeine market is projected to keep a leading position in the global codeine market and contribute the largest market share during the forecast period.

Tris Pharma, Inc. got FDA permission and released Tuzistra XR (codeine polistirex and chlorpheniramine polistirex), a prolonged oral suspension, CIII (DEA Schedule III) in the United States in 2015. Tuzistra XR is used to cure and relieve cough and other symptoms caused by upper respiratory allergies or a common cold in individuals over the age of 18.

Restraints

In the coming years, strict rules in key areas for codeine formulation are projected to be a major factor limiting the global codeine market's growth. In February 2018, Australia's Therapeutic Goods Administration categorized codeine, which was formerly accessible over-the-counter, as a prescription-only pharmaceutical. The reason for this categorization was that long-term usage of codeine-containing medications can lead to addiction.

In 2017, Health Canada suggested banning the sale of non-prescription codeine. Codeine's reclassification as a prescription medicine is projected to stifle its sales and uptake, limiting the global codeine market's growth during the forecast period.

To get detailed table of content (ToC), please click - https://www.coherentmarketinsights.com/ongoing-insight/toc/2297

Competitive Landscape

Major companies contributing in the global codeine market are Larken Laboratories, Inc., Wraser Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd., Nexgen Pharma, Inc., Johnson & Johnson, Tris Pharma Inc., Sun Pharmaceutical Industries Limited, and Aurobindo Pharma Limited.

Table of Content

Global Codeine Market Research Report

Section 1: Global Codeine Industry Overview

Section 2:  Global Economic Impact on Codeine Industry

Section 3:  Global Market Competition by Industry Producers

Section 4:  Global Productions, Revenue (Value), according to Regions

Section 5:  Global Supplies (Production), Consumption, Export, Import, geographically

Section 6:  Global Productions, Revenue (Value), Price Trend, Product Type

Section 7:  Global Market Analysis, on the basis of Application

Section 8:  Codeine Market Pricing Analysis

Section 9:  Market Chain, Sourcing Strategy and Downstream Buyers

Section 10:  Strategies and key policies by Distributors/Suppliers/Traders

Section 11:  Key Marketing Strategy Analysis, by Market Vendors

Section 12:  Market Effect Factors Analysis

Section 13:  Global Codeine Market Forecast

Have a Look at Related Research Insights:

NARCOTICS ANALGESICS MARKET ANALYSIS

NEUROLOGICAL DISORDER DRUGS MARKET ANALYSIS

OVER-THE-COUNTER DRUGS MARKET ANALYSIS

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837